SEC Filing Summary: Safety Shot, Inc. (SHOT) - Form 10-Q
Business Context and Reporting Period
Company: Safety Shot, Inc. (formerly Jupiter Wellness, Inc.)
Reporting Period: Quarter and Six Months ended June 30, 2024
Business Overview: The Company acquired the "Safety Shot" dietary supplement assets in August 2023, which aims to lower blood alcohol content. The product launched in December 2023 via e-commerce and select retailers. The Company is classified as a "smaller reporting company" and an "emerging growth company."
Key Financial Metrics (Six Months Ended June 30, 2024)
| Metric | Value |
|---|---|
| Revenue | $880,972 |
| Cost of Sales | $2,887,813 |
| Gross Profit (Loss) | $(2,006,841) |
| Operating Expenses | $21,575,170 |
| Net Loss | $(23,948,765) |
| Cash and Cash Equivalents | $3,223,783 |
| Working Capital | $2,577,472 |
| Total Liabilities | $4,225,173 |
| Convertible Notes Payable | $1,569,669 |
| Accumulated Deficit | $(89,629,480) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased significantly from $58,093 in the prior year period to $880,972, driven by the December 2023 product launch.
- Gross Margin Deterioration: The Company reported a gross loss of $(2.0M) compared to a gross profit of $6,553 in the prior year. This was primarily due to a one-time inventory write-down of $1,649,473 related to rebranding and startup costs.
- Operating Expenses Surge: Total operating expenses jumped from $2.99M to $21.58M. The primary driver was stock-based compensation, which totaled $11.05M (including $10.27M in fair value of options granted). Legal and professional fees also rose to $4.25M due to ongoing litigation.
- Net Loss Expansion: Net loss widened from $(1.67M) to $(23.95M) due to the aforementioned expense increases and inventory write-downs.
- Investment Activity: The Company sold all remaining shares of Chijet (CJET) marketable securities and sold a portion of its SRM Entertainment investment, realizing a gain of $432,548 on the SRM sale.
Guidance, Outlook, Risks, and Unusual Items
- Going Concern: The Company's auditors have raised substantial doubt about its ability to continue as a going concern due to accumulated deficits and negative cash flows from operations ($12.1M used in six months). Management expects to incur significant costs for expansion.
- Capital Needs: The Company may need to raise additional capital to execute its business plan. There is no assurance that financing will be available on acceptable terms.
- Legal Proceedings: The Company is facing multiple lawsuits (Intracoastal Capital, Sabby Volatility Warrant Master Fund, 3i LP, Bigger Capital, Alta Partners) alleging breach of contract regarding warrant exercises. Total claimed damages exceed $10 million. Management intends to vigorously defend these claims.
- Internal Controls: Management concluded that disclosure controls and procedures were ineffective as of June 30, 2024, citing insufficient segregation of duties and a lack of formalized policy documentation. Remediation plans are underway.
- Unusual Items: Significant non-cash expenses included $10.27M in stock-based compensation for options granted and a $1.65M inventory write-down.
Investor Verification Checklist
- Cash Runway: Verify the sufficiency of the $3.2M cash balance against the current burn rate of approximately $6M per quarter.
- Inventory Valuation: Confirm the rationale and accounting treatment of the $1.65M inventory write-down for rebranding.
- Stock-Based Compensation: Review the valuation assumptions (Black-Scholes) for the $10.27M in options granted, noting the high volatility inputs used.
- Legal Exposure: Assess the potential financial impact of the six pending warrant-related lawsuits and the likelihood of settlement or adverse judgment.
- Internal Controls: Monitor the progress of remediation efforts regarding the ineffective disclosure controls and procedures.
- Debt Obligations: Review the terms of the $1.57M convertible notes, including the recent amendment allowing interest payment in stock and the September 2024 maturity date.